HomeCompareTSVT vs NOBL

TSVT vs NOBL: Dividend Comparison 2026

TSVT yields 40.00% · NOBL yields 2.17%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 TSVT wins by $209.0K in total portfolio value
10 years
TSVT
TSVT
● Live price
40.00%
Share price
$5.00
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$231.9K
Annual income
$39,181.04
Full TSVT calculator →
NOBL
NOBL
● Live price
2.17%
Share price
$104.67
Annual div
$2.27
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$22.9K
Annual income
$249.78
Full NOBL calculator →

Portfolio growth — TSVT vs NOBL

📍 TSVT pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodTSVTNOBL
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, TSVT + NOBL cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
TSVT pays
NOBL pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

TSVT
Annual income on $10K today (after 15% tax)
$3,400.00/yr
After 10yr DRIP, annual income (after tax)
$33,303.88/yr
NOBL
Annual income on $10K today (after 15% tax)
$184.52/yr
After 10yr DRIP, annual income (after tax)
$212.31/yr
At 15% tax rate, TSVT beats the other by $33,091.57/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of TSVT + NOBL for your $10,000?

TSVT: 50%NOBL: 50%
100% NOBL50/50100% TSVT
Portfolio after 10yr
$127.4K
Annual income
$19,715.41/yr
Blended yield
15.48%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on TSVT right now

TSVT
Analyst Ratings
4
Buy
6
Hold
Consensus: Hold
Price Target
$3.50
-30.0% upside vs current
Range: $2.00 — $5.00
Altman Z
-1.0
Piotroski
2/9
NOBL
No analyst data
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

TSVT buys
0
NOBL buys
0
No recent congressional trades found for TSVT or NOBL in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricTSVTNOBL
Forward yield40.00%2.17%
Annual dividend / share$2.00$2.27
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%0%
Portfolio after 10y$231.9K$22.9K
Annual income after 10y$39,181.04$249.78
Total dividends collected$174.4K$2.3K
Payment frequencyquarterlyquarterly
SectorStockETF

Year-by-year: TSVT vs NOBL ($10,000, DRIP)

YearTSVT PortfolioTSVT Income/yrNOBL PortfolioNOBL Income/yrGap
1← crossover$14,700$4,000.00$10,917$217.08+$3.8KTSVT
2$21,224$5,495.33$11,903$221.48+$9.3KTSVT
3$30,125$7,415.26$12,962$225.68+$17.2KTSVT
4$42,071$9,836.48$14,099$229.68+$28.0KTSVT
5$57,854$12,838.17$15,319$233.49+$42.5KTSVT
6$78,403$16,499.54$16,628$237.10+$61.8KTSVT
7$104,788$20,897.28$18,033$240.53+$86.8KTSVT
8$138,226$26,102.79$19,539$243.78+$118.7KTSVT
9$180,082$32,179.61$21,154$246.86+$158.9KTSVT
10$231,869$39,181.04$22,884$249.78+$209.0KTSVT

TSVT vs NOBL: Complete Analysis 2026

TSVTStock

2seventy bio, Inc., a cell and gene therapy company, focuses on the research, development, and commercialization of treatments for cancer in the United States. Its products pipeline includes idecabtagene vicleucel; ide-cel or Abecma and bb21217; and CAR-T cell product candidates for the treatment of multiple myeloma. 2seventy bio, Inc. has a collaboration arrangement with Bristol-Myers Squibb Company. The company was incorporated in 2021 and is headquartered in Cambridge, Massachusetts.

Full TSVT Calculator →

NOBLETF

The fund will invest at least 80% of its total assets in component securities of the index. The index contains a minimum of 40 stocks, which are equally weighted, and no single sector is allowed to comprise more than 30% of the index weight. It seeks to remain fully invested at all times in securities and/or financial instruments that, in combination, provide exposure to the returns of the index without regard to market conditions, trends or direction.

Full NOBL Calculator →
📬

Get this TSVT vs NOBL comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

TSVT vs SCHDTSVT vs JEPITSVT vs OTSVT vs KOTSVT vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.